Stereotaxis Inc (AMEX:STXS)

Q1 2025 Stereotaxis Inc Earnings Call Transcript

May 12, 2025 / 08:30 PM GMT

Release Date Price: $2.07 (-2.82%)

Transcript 10-Q8-K

Key Points

Positve

Stereotaxis Inc (STXS) reported a solid 9% year-over-year revenue growth for Q1 2025.
The company is seeing commercial progress with its differentiated EP catheters, including the recently approved Magic catheter in Europe.
Recurring revenue growth is driven by the Mapi family of diagnostic EP catheters, with sales in the US growing 30% sequentially.
Stereotaxis Inc (STXS) received European approval for the Magic ablation catheter, with initial sales expected to ramp up significantly.
The company is preparing for the first commercial installation of Genesis X, which is expected to drive robotic system growth.

Negative

Structural challenges of the old product ecosystem remain a significant headwind for Stereotaxis Inc (STXS).
The process of getting catheters adopted is gradual, requiring administrative efforts and clinical support.
Recurring revenue gross margins are impacted by acquisition-related accounting, temporarily reducing disposable margins.
Operating loss and net loss increased compared to the previous year, with operating expenses rising due to acquisition-related costs.
Uncertainty in the Chinese market and macroeconomic conditions could impact potential revenue from Genesis systems.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

STXS.A - Stereotaxis Inc
Q1 2025 Stereotaxis Inc Earnings Call
May 12, 2025 / 08:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good afternoon.

Thank you for joining us for your taxes first quarter 2025 earnings conference call. Certain statements during the conference call and question and answer period to follow may relate to future events, expectations, and as such constitute forward-looking statements within the meaning of the privacy. Securities Litigation Reform Act of 1,995. Such statements involve known and unknown risks, uncertainties, and other factors which may cause the actual results, performance, or achievements of the company in the future to be materially different from the statements that the company's executives may make today.

These risks are described in detail in our public filings with the Securities and Exchange Commission,

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.